Literature DB >> 25482925

Analysis of platelet function and dysfunction.

K Jurk1.   

Abstract

Although platelets act as central players of haemostasis only their cross-talk with other blood cells, plasma factors and the vascular compartment enables the formation of a stable thrombus. Multiple activation processes and complex signalling networks are responsible for appropriate platelet function. Thus, a variety of platelet function tests are available for platelet research and diagnosis of platelet dysfunction. However, universal platelet function tests that are sensitive to all platelet function defects do not exist and therefore diagnostic algorithms for suspected platelet function disorders are still recommended in clinical practice. Based on the current knowledge of human platelet activation this review evaluates point-of-care related screening tests in comparison with specific platelet function assays and focuses on their diagnostic utility in relation to severity of platelet dysfunction. Further, systems biology-based platelet function methods that integrate global and specific analysis of platelet vessel wall interaction (advanced flow chamber devices) and post-translational modifications (platelet proteomics) are presented and their diagnostic potential is addressed.

Entities:  

Keywords:  Platelet function; platelet pathology; platelet physiology; point-of-care testing; proteomics; thrombin

Mesh:

Year:  2014        PMID: 25482925     DOI: 10.5482/HAMO-14-09-0047

Source DB:  PubMed          Journal:  Hamostaseologie        ISSN: 0720-9355            Impact factor:   1.778


  8 in total

1.  Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia.

Authors:  Xiaoli Wei; Jie Gao; Ronnie H Fang; Brian T Luk; Ashley V Kroll; Diana Dehaini; Jiarong Zhou; Hyeon Woo Kim; Weiwei Gao; Weiyue Lu; Liangfang Zhang
Journal:  Biomaterials       Date:  2016-10-05       Impact factor: 12.479

2.  Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy.

Authors:  Efthymios Arvanitidis; Sergio Bizzarro; Elena Alvarez Rodriguez; Bruno G Loos; Elena A Nicu
Journal:  Thromb J       Date:  2017-02-06

3.  Effects of Clopidogrel, Prasugrel and Ticagrelor on Microvascular Function and Platelet Reactivity in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized, Blinded, Parallel Group Trial.

Authors:  Boris Schnorbus; Kerstin Jurk; Karl J Lackner; Caroline Welk; Thomas Münzel; Tommaso Gori
Journal:  Front Cardiovasc Med       Date:  2021-12-13

Review 4.  Implication of Platelets in Immuno-Thrombosis and Thrombo-Inflammation.

Authors:  Younes Zaid; Yahye Merhi
Journal:  Front Cardiovasc Med       Date:  2022-03-25

5.  Differential Inhibition of Platelet Reactivity by Dual Therapy With Aspirin and Low-Dose Rivaroxaban in Peripheral Arterial Disease: A Pilot Study.

Authors:  Kerstin Jurk; Korbinian F Rothenaicher; Kathrin Groß; Heidi Rossmann; Gerhard Weißer; Irene Schmidtmann; Thomas Münzel; Christine Espinola-Klein
Journal:  Front Cardiovasc Med       Date:  2022-05-06

6.  Age-Dependent Control of Collagen-Dependent Platelet Responses by Thrombospondin-1-Comparative Analysis of Platelets from Neonates, Children, Adolescents, and Adults.

Authors:  Katrin Herken; Martin Glauner; Stefanie C Robert; Matthias Maas; Sonja Zippel; Ulrike Nowak-Göttl; Barbara Zieger; Judith Lahav; Anke C Fender; Kerstin Jurk; Beate E Kehrel
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

7.  The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets.

Authors:  Elena J Kumm; Oliver Pagel; Stepan Gambaryan; Ulrich Walter; René P Zahedi; Albert Smolenski; Kerstin Jurk
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

8.  Feedback Regulation of Syk by Protein Kinase C in Human Platelets.

Authors:  Stephanie Makhoul; Stephanie Dorschel; Stepan Gambaryan; Ulrich Walter; Kerstin Jurk
Journal:  Int J Mol Sci       Date:  2019-12-25       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.